Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice. 2007

Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
Radiation Effect Mechanisms Research Group, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. ishii_h@nirs.go.jp <ishii_h@nirs.go.jp>

Severe combined immune deficiency (SCID) mice exhibit limited repair of DNA double-strand breaks and are sensitive to ionizing radiation due to a mutation of the DNA-dependent protein kinase catalytic subunit gene. To elucidate the effects of deficient DNA double-strand break repair on radiation-induced carcinogenesis, the dose-response relationship for the induction of all tumor types was examined in wild-type and SCID mice. In wild-type mice, the incidence of thymic lymphomas at gamma-ray doses up to 1 Gy was almost equal to the background level, increased gradually above 1 Gy, and reached a maximum of 12.5% at 5 Gy, which is indicative of a threshold dose of less than 1 Gy. SCID mice were extremely susceptible to the induction of spontaneous and radiation-induced thymic lymphomas. The incidence of thymic lymphomas in SCID mice irradiated with 0.1 Gy or less was similar to the background level; that is, it increased markedly from 31.7% at 0.1 Gy to 51.4% at 0.25 Gy, and reached a maximum of 80.6% at 2 Gy, suggesting the presence of a threshold-like dose at low gamma-ray doses, even in radiosensitive SCID mice. As the average latency for the induction of thymic lymphomas at 0.1 Gy was significantly shortened, the effect of 0.1 Gy gamma-rays on thymic lymphoma induction was marginal. The high susceptibility of SCID mice to develop thymic lymphomas indicates that thymic lymphomas are induced by a defect in DNA double-strand break repair or V(D)J recombination. Excessive development of tumors other than thymic and nonthymic lymphomas was not observed in SCID mice. Furthermore, our data suggest that the defective double-strand break repair in SCID mice is not a major determinant for the induction of nonlymphoid tumors.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse

Related Publications

Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
January 1991, Carcinogenesis,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
August 2001, Oncogene,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
January 1983, Haematology and blood transfusion,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
January 1992, Progress in clinical and biological research,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
July 2006, Molecular carcinogenesis,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
July 1987, Cancer research,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
August 2003, Cancer science,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
November 1999, Molecular carcinogenesis,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
August 1989, Leukemia,
Hiroko Ishii-Ohba, and Shigeru Kobayashi, and Mayumi Nishimura, and Yoshiya Shimada, and Hideo Tsuji, and Toshihiko Sado, and Toshiaki Ogiu
September 1999, Journal of radiation research,
Copied contents to your clipboard!